Hello all,
We'll have out next Geuvadis analysis group TC on Thursday January 2 at
2pm.
Lots of things on the agenda:
- sequencing updates
- analysis group face-to-face meeting: time, duration, location
- abstract for the Biology of Genomes meeting at Cold Spring Harbor
- Marc will present results of the DNA contamination analysis
- miRNA data processing and QC
- analysis plans (see below)
As we discussed on the last call, I'd like to start putting together a
plan of what we all eventually want to do with the data. The data is of
course shared and everyone is free to do what they want, but we need to
make sure that the essentials get done and that there's no unnecessary
overlap. As a starting point for discussion, take a look at the analysis
breakdown draft that I wrote
(https://docs.google.com/document/d/1_LAkv0NGSrXU6LSsyhN_GnZB4WRanl-e993U_0I…),
and feel free to edit it before/during the call.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
Here are minutes of the Geuvadis analysis group TC on January 12.
The next call has to be pushed forward by one week to *February 2 at
2pm. *We'll continue with the normal schedule after that, so the one
after that will be February 9.
best regards,
Tuuli
Action items:
- Tuuli:
Set up a call for next week to discuss imputation details with
Natalja, Micha, Tim.
Continue masked mapping tests
- Esther, Peter, Natalja:
Send an outline of you miRNA analysis pipeline to the analysis
group mailing list
- Everyone:
Think and discuss in your lab about the analyses that you'd want to
do (lead and/or participate) with this dataset, by the next call
- Micha:
Continue mapping tests
- *Attending:* Tuuli, Micha, Esther, Ivo, Tim, Thomas x2, Mathias,
Peter, Olof, Matthias, Natalja
- *Sequencing:* Most of the labs will be able to meet the initial
deadline of Feb 15 despite the delays in kit delivery, which is great.
We agreed to keep the very last deadline of March 15; all the samples
and reruns should be done and data submitted by then.
- *Genotypes*: We need to impute about 40 samples that are not in 1000g
Phase 1 (they have Omni 2.5M haplotypes). Natalia/EBI could probably do
this, and Tuuli, Micha and Tim & co. want to be involved/informed too.
This should be done within a month.
- *miRNA analysis pipeline*: The labs who have experience of miRNA
analysis will send around details of how they map and quantify miRNAs.
We'll discuss on the next call how we should analyze them.
- *A new collaboration:* Mark McMarthy from Oxford is a long-term
collaborator of Manolis. They've developed a new kind of a burden test
to look at rare variant effects, and expressed interest in doing some
analysis with the Geuvadis data. People were positive about this, and
Mark's postdoc Manuel Rivas will present their plans in a future TC.
- *Analysis plans*: Tuuli would like to coordinate the future analyses
so that the essentials get done and there's no unnecessary overlaps. For
this we also need to assign people who will lead/participate/be informed
for each set of analysis. In the next call we'll start putting together
a list of what will be done and by whom.
- *Analysis group face-to-face meeting*: It would be good to get
together to discuss in real life once the data is ready and gone through
basic pipelines - maybe around April.
- *mRNA mapping*: The GEM paper will be submitted soon, so we might want
to use Micha's pipeline for mapping, quantification and normalization as
the basic approach. Micha presented some slides about an approach that
they're developing for SNP calling from RNAseq data, based on excessive
mapping. Tuuli presented results suggesting that reference allele
mapping bias affects exon quantifications. We should correct for it e.g.
by mapping to a masked reference.
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all, at the request of Tuuli, please fill in this doodle<http://www.doodle.com/ccm7dkvtngwwquqt> for the next GEUVADIS RNAseq TC.
Preliminary agenda:
- update on sequencing progress
- preliminary QC/analysis results
- analysis plans
- analysis group meeting in the spring
Kind regards,
Gabrielle
http://www.doodle.com/ccm7dkvtngwwquqt
Hi all,
Here are some slides about reference allele bias corrections in mapping
for the Geuvadis analysis group TC that will be in 10 minutes.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
We'll have the Geuvadis RNAseq analysis group call this Thursday,
January 12, at 14-15pm. I hope many of you can attend.
We should discuss at least the following things:
- updates on sequencing progress and deadlines
- genotypes and imputation
- mRNA mapping and quantification approaches (Tuuli will present a few
slides)
- miRNA analysis pipeline
- possible collaboration with Mark McCarthy's group
Call details:
Spain
902 125 136
Other countries
+34 91 495 18 99
Participants' Pin-code:
764989*
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hello and happy new year!
The first batch of Geuvadis mRNAseq data from UNIGE is now available at
the ftp site.
If you're interested in taking a look at these 103 samples, feel free to
do so. The fastq files and the sample info can be found from
/upload/geuvadis/wp4_rnaseq/main_project/sequence_data/fastq/mrna
Of these data, I've defined sandbox datasets for testing purposes as we
discussed - see the Analysis page of the wiki. There's a small set of 5
samples that I chose to be those that we're doing in replicate in all
the labs. For a little big bigger scale testing, I fixed a set of 24
samples (the 5+19 others). Of these 24, I have uploaded the bam files
from mapping with bwa in:
/upload/geuvadis/wp4_rnaseq/main_project/working/mapping/bam/normal_hg19/bwa
.
As agreed before, we'll have an *analysis group TC next week, January
12, at 2pm*. I'll send the agenda (and a reminder) next week.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch